CClinicalTrials.gg
RecruitingNCT06591780Updated Mar 11, 2026

Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy

An interventional study of Clinical Evaluation and Plantar Pressure Biofeedback Gait Training in Diabetic Peripheral Neuropathy and Diabetes Mellitus, sponsored by Florida Institute for Human and Machine Cognition. Recruiting at 1 site in United States. Open to participants aged 45 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-03-11.

Sponsored by Florida Institute for Human and Machine Cognition · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
45 Years to 90 Years
Sex
All
01

Study summary

This study aims to collect data to improve gait function in individuals with Diabetic Peripheral Neuropathy (DPN).

The primary goals are to evaluate:

  • Biomechanical mechanisms contributing to abnormal plantar pressure and propulsion during gait in individuals with DPN
  • Biofeedback-induced changes in plantar pressure, propulsion, and biomechanics during gait in individuals with DPN

The participants will be required to complete

  • Questionnaires
  • Clinical examination
  • 3-Dimensional gait analysis on an instrumented treadmill
  • Visual and auditory biofeedback on the participant's propulsion and plantar pressure metrics provided by a projector screen during walking
Read the detailed description

Over 38 million adults in the United States (\~1 in 7) are living with Diabetes Mellitus (DM), of which diabetic peripheral neuropathy (DPN) is the most common complication, affecting more than 50% of individuals with DM. DPN causes both sensory and motor impairments of the foot and ankle, leading to reduced functional mobility and increased ulceration and amputation risk. Propulsion and plantar pressure are two key interrelated gait parameters contributing to walking function and ulceration risk, respectively. Real-time biofeedback is a non-invasive rehabilitation strategy with significant promise for targeting gait impairments by providing the user with quantitative information regarding a targeted performance variable.

In this study, the team will evaluate multi-joint lower extremity biomechanical responses to univariate propulsion and plantar pressure biofeedback. Secondly, the team will use identified biomechanical compensations to propulsion and plantar pressure biofeedback to develop a multi-variable, implicit, individualized visual biofeedback program to improve gait function in individuals with DPN. Insights into the biomechanical mechanisms underlying plantar pressure and propulsion in people with DPN will allow us to design more informed and effective gait rehabilitation interventions aimed at preventing deleterious outcomes such as ulceration and amputation that can be tailored to individual patient characteristics.

02

Conditions studied

  • Diabetic Peripheral Neuropathy
  • Diabetes Mellitus

Browse trials for

Keywords

  • anterior ground reaction force
  • biofeedback-induced changes in plantar pressure
  • diabetic peripheral neuropathy
03

Who can participate

Ages eligible
45 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Able to walk 10-meters independently without an assistive device
  • Sufficient cardiovascular and musculoskeletal health to walk on a treadmill for 6 minutes at a self-selected speed
  • Diagnosis of diabetes mellitus
  • Diagnosis of diabetic peripheral neuropathy by a physician
  • Foot examination within the past 6 months documenting ambulatory status
  • Physician clearance

Exclusion criteria

Exclusion Criteria:

  • History of amputation
  • Active ulceration
  • Medial column deformity
  • Severe cognitive impairment (MoCA \< 10)
  • Severe visual impairment
  • History of Charcot osteoarthropathy
  • History of posterior muscle group lengthening
  • History of lower extremity joint replacement
  • History of lower extremity and/or foot surgery affecting walking mechanics
  • Orthopaedic problems of the lower limbs or spine due to other medical conditions (not diabetes or DPN) that limit walking or cause pain during walking
  • Improper footwear for walking and community ambulation
  • Cardiovascular or medical condition affecting ability to walk safely
  • History of unexplained dizziness or fainting in the past 2 months
  • Allergy to adhesive tape or rubbing alcohol
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    Real-Time Biofeedback Walking Trials

    Real-time biofeedback of propulsion and plantar pressure to measure the immediate effects of biofeedback on walking function and gait mechanics. Permuted block randomization (blocks of 4) will be used to allocate the order of the biofeedback stimulus (plantar pressure-intervention A or propulsion-intervention B). Participants will receive both interventions in session 3, but the order will be randomized.

    Other: Clinical Evaluation · Other: Plantar Pressure Biofeedback Gait Training · Other: Propulsion Biofeedback Gait Training

Interventions

  • OtherClinical Evaluation

    A clinical evaluation occurs at the first study session. The clinical evaluation assesses walking function and mobility, lower extremity, sensation, health-related quality of life (HRQoL) and foot function. Session 2 will be a dynamometer-based evaluation of passive ankle stiffness and a 3-dimensional gait analysis to evaluate baseline biomechanics. During Session 3, real-time biofeedback conditions will be used to measure the immediate effects on walking function.

  • OtherPlantar Pressure Biofeedback Gait Training

    Participants will complete a 3-dimensional gait evaluation prior to training, after a 6-minute control bout without biofeedback, and following three 6-minute biofeedback training bouts (total 18-minutes). Individualized biofeedback targets will be calculated from each participant's immediate biofeedback session to best minimize plantar pressure whilst maintaining or enhancing propulsion. Audio-visual biofeedback is provided using a screen placed in front of the treadmill and a speaker. For plantar pressure biofeedback, a visual display of a foot with a colored heat map represents the current plantar pressure, in addition to bar graphs representing real-time movement of plantar pressure in specific areas of the foot. A target is provided using the heat map colors of red and target line on the bar graph. Participants are informed that the target is a measurement of the pressure under their foot, and their goal is to decrease pressure to achieve their target

    Also known as: Intervention A

  • OtherPropulsion Biofeedback Gait Training

    Participants will complete a 3-dimensional gait evaluation prior to training, after a 6-minute control bout without biofeedback, and following three 6-minute biofeedback training bouts (total 18-minutes). Individualized biofeedback targets will be calculated from each participant\&#39;s immediate biofeedback session to best minimize plantar pressure whilst maintaining or enhancing propulsion. Audio-visual biofeedback is provided using a screen placed in front of the treadmill and a speaker. For propulsion biofeedback, a visual display with a marker represents the current propulsion (peak AGRF) and a target provided to modulate propulsion. Participants are informed that the marker is a measurement of how hard they are pushing the ground backward, and their goal is to push-off more to achieve their target.

    Also known as: Intervention B

05

What researchers measure

Primary outcomes

  1. Biomechanical plantar pressure

    Plantar pressure is calculated in kilopascals (kPa) using a force sensor placed between the participant's foot and insole of their shoe. The peak plantar pressure in regions of interest (forefoot) will be calculated.

    Time frame: Study Session 2 (occurs 24 hours up to 2 weeks after Session 2)

  2. Biomechanical Propulsion

    Propulsion is calculated as the maximum anteriorly directed ground reaction force during the stance phase of gait using the instrumented (force plate) treadmill.

    Time frame: Study Session 2 (occurs 24 hours up to 2 weeks after Session 2)

Secondary outcomes

  1. Changes induced by biofeedback in plantar pressure

    Plantar pressure measurements will be recorded using insoles placed between the surface of the foot and the insole of the participant's shoe. Marker data, GRFs, and plantar pressure data will be synchronized.

    Time frame: Study Session 3 (occurs 24 hours up to 2 weeks after Session 3)

  2. Changes induced by biofeedback in propulsion

    Ground reaction force (GRF) data will be collected independently from each leg using a split-belt treadmill instrumented with two 6-degree of freedom force platforms. The antero-posterior GRFs (AGRF) will be used to compute propulsion.

    Time frame: Study Session 3 (occurs 24 hours up to 2 weeks after Session 3)

  3. Changes induced by biofeedback in biomechanics during gait

    Lower extremity kinetics and kinematics will be measured using a three-dimensional motion analysis system and split-belt instrumented treadmill. Kinetics and kinematics of the ankle, knee, and hip will be analyzed during gait.

    Time frame: Study Session 3 (occurs 24 hours up to 2 weeks after Session 3)

06

Study locations

1 of 1 sites recruiting
  • Florida Institute for Human and Machine Cognition
    Pensacola, Florida 32502, United States
    • Nicole K Rendos, PhD · Contact · 850-202-4442
    Recruiting
07

References and documents

Individual participant data

Plan to share: Yes — Data on demographics, medical history, clinical evaluation, questionnaires, walking biomechanics, and plantar pressure data will be collected from individuals (N = 25) with diabetic peripheral neuropathy. Subject-level de-identified data will be preserved and shared in raw and pre-processed forms in ".csv" and ".xlsx" format. Biomechanics data will be processed and saved in ".c3d" formatted files as per standard practice in the field of biomechanics.

Supporting information: Study protocol, Sap, Icf

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT06591780
Lead sponsor
Florida Institute for Human and Machine Cognition
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Responsible party
Nicole Rendos (Research Scientist, Florida Institute for Human and Machine Cognition) — Principal investigator
First posted
Sep 19, 2024
Start date
Oct 20, 2025
Primary completion
Jun 1, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Mar 11, 2026

Study contacts

Nicole K Rendos, PhD
Contact
nrendos@ihmc.org
(404) 202-4442
Craig Tuggle
Contact
ctuggle@ihmc.org
850-202-4462
Nicole K Rendos, PhD
principal investigator · Florida Institute for Human and Machine Cognition

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion